Marta Munar-Bestard
Overview
Explore the profile of Marta Munar-Bestard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Munar-Bestard M, Vargas-Alfredo N, Ramis J, Monjo M
Int J Biol Macromol
. 2024 Aug;
279(Pt 1):135187.
PMID: 39216568
Periodontal disease (PD) prevention and treatment products typically demonstrate excellent antibacterial activity, but recent studies have raised concerns about their toxicity on oral tissues. Therefore, finding a biocompatible alternative that...
2.
Llopis-Grimalt M, Munar-Bestard M, Ramis-Munar G, Smith D, Starborg T, Kadler K, et al.
ACS Omega
. 2024 Jul;
9(28):30534-30543.
PMID: 39035935
Improved soft tissue integration (STI) around dental implants is key for implant success. The formation of an early and long-lasting transmucosal seal around the implant abutment might help to prevent...
3.
Munar-Bestard M, Rodriguez-Fernandez A, Ramis J, Monjo M
ACS Pharmacol Transl Sci
. 2024 May;
7(5):1507-1517.
PMID: 38751630
Skin and oral tissue infections pose significant health challenges worldwide, necessitating the exploration of new antiseptic agents that are both effective and biocompatible. This study evaluated the antibacterial efficacy and...
4.
Ferra-Canellas M, Munar-Bestard M, Floris I, Ramis J, Monjo M, Garcia-Sureda L
Int J Mol Sci
. 2023 Jul;
24(13).
PMID: 37445663
Periodontal therapies use immune mediators, but their side effects can increase with dosage. Micro-immunotherapy (MI) is a promising alternative that employs immune regulators at low and ultralow doses to minimize...
5.
Munar-Bestard M, Villa O, Ferra-Canellas M, Ramis J, Monjo M
J Vis Exp
. 2023 Mar;
(192).
PMID: 36876950
Periodontitis (PD) is a highly prevalent, chronic immune-inflammatory disease of the periodontium, that results in a loss of gingival soft tissue, periodontal ligament, cementum, and alveolar bone. In this study,...
6.
Vargas-Alfredo N, Munar-Bestard M, Ramis J, Monjo M
Gels
. 2022 Oct;
8(10).
PMID: 36286131
Gelatin methacryloyl (GelMA) hydrogels have been widely used for different biomedical applications due to their tunable physical characteristics and appropriate biological properties. In addition, GelMA could be modified with the...
7.
Antich-Rossello M, Munar-Bestard M, Forteza-Genestra M, Calvo J, Gaya A, Monjo M, et al.
Int J Mol Sci
. 2022 Jul;
23(14).
PMID: 35887008
Gingival regeneration aims at restoring the architecture and functionality of oral damaged tissue. Different biomaterials or biological materials have been tested for tissue repair, such as platelet concentrates such as...
8.
Munar-Bestard M, Llopis-Grimalt M, Ramis J, Monjo M
Pharmaceutics
. 2021 Sep;
13(9).
PMID: 34575578
In the last years, several studies testing commercial periodontal gels that contain chlorhexidine (CHX) or other antibacterial agents, have raised concerns regarding their cytotoxicity in periodontal tissues. We aimed at...
9.
Ferra-Canellas M, Munar-Bestard M, Garcia-Sureda L, Lejeune B, Ramis J, Monjo M
J Periodontol
. 2021 Jan;
92(10):1448-1459.
PMID: 33393105
Background: We aimed to evaluate the effect of low doses (LD) bone morphogenetic protein-2 (BMP2) and BMP4 micro-immunotherapy (MI) in two in vitro models of periodontal wound healing/regeneration. Methods: We...
10.
Torrens G, Barcelo I, Perez-Gallego M, Escobar-Salom M, Tur-Gracia S, Munar-Bestard M, et al.
Sci Rep
. 2020 Mar;
10(1):4356.
PMID: 32132557
An amendment to this paper has been published and can be accessed via a link at the top of the paper.